Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 61

1.

Clinical, demographic and laboratory parameters at HAART initiation associated with decreased post-HAART survival in a U.S. military prospective HIV cohort.

Lifson AR, Krantz EM, Grambsch PL, Macalino GE, Crum-Cianflone NF, Ganesan A, Okulicz JF, Eaton A, Powers JH, Eberly LE, Agan BK; Infectious Disease Clinical Research Program HIV/STI Working Group.

AIDS Res Ther. 2012 Feb 10;9(1):4. doi: 10.1186/1742-6405-9-4.

2.

Long-term CD4+ lymphocyte response following HAART initiation in a U.S. Military prospective cohort.

Lifson AR, Krantz EM, Eberly LE, Dolan MJ, Marconi VC, Weintrob AC, Crum-Cianflone NF, Ganesan A, Grambsch PL, Agan BK; Infectious Disease Clinical Research Program (IDCRP) HIV Working Group.

AIDS Res Ther. 2011 Jan 18;8(1):2. doi: 10.1186/1742-6405-8-2.

3.

Early-onset Major Depressive Disorder in men is associated with childlessness.

Yates WR, Meller WH, Lund BC, Thurber S, Grambsch PL.

J Affect Disord. 2010 Jul;124(1-2):187-90. doi: 10.1016/j.jad.2009.10.024.

PMID:
19931182
4.

Intermittent calorie restriction delays prostate tumor detection and increases survival time in TRAMP mice.

Bonorden MJ, Rogozina OP, Kluczny CM, Grossmann ME, Grambsch PL, Grande JP, Perkins S, Lokshin A, Cleary MP.

Nutr Cancer. 2009;61(2):265-75. doi: 10.1080/01635580802419798.

PMID:
19235043
5.

A decision rule for sequential monitoring of clinical trials with a primary and supportive outcome.

Zhao Y, Grambsch PM, Neaton JD.

Clin Trials. 2007;4(2):140-53.

PMID:
17456513
7.

Estimation of cancer drug potencies and relative potencies from in vitro data.

Le Chap T, Grambsch PM, Liu A.

J Biopharm Stat. 2005;15(6):903-12.

PMID:
16279350
8.

Survival analysis for a large-scale forest health issue: Missouri oak decline.

Woodall CW, Grambsch PL, Thomas W, Moser WK.

Environ Monit Assess. 2005 Sep;108(1-3):295-307.

PMID:
16160793
9.

Results of the Controlled ONset Verapamil INvestigation of Cardiovascular Endpoints (CONVINCE) trial by geographical region.

Black HR, Elliott WJ, Grandits G, Grambsch P, Lucente T, Neaton JD, Grimm RH Jr, Hansson L, Lacourcière Y, Muller JE, Sleight P, Weber MA, White WB, Williams GH, Wittes J, Zanchetti A, Anders RJ; CONVINCE Research Group.

J Hypertens. 2005 May;23(5):1099-106.

PMID:
15834298
10.

Design and analysis of in vitro experiments for combination chemotherapy.

Le Chap T, Grambsch PM.

J Biopharm Stat. 2005;15(1):179-86.

PMID:
15702612
11.

Pulsatile luteinizing hormone disruption in depression.

Grambsch P, Young EA, Meller WH.

Psychoneuroendocrinology. 2004 Aug;29(7):825-9.

12.

Quality control and the identification of vaccine responders using ELISA-derived antibody data.

Le CT, Grambsch PM, Giebink GS.

Stat Med. 2003 Sep 30;22(18):2935-42.

PMID:
12953289
13.

Evaluation of sampling strategies for modeling survival of uveal malignant melanoma.

Kivelä T, Grambsch PM.

Invest Ophthalmol Vis Sci. 2003 Aug;44(8):3288-93.

PMID:
12882772
14.

Principal results of the Controlled Onset Verapamil Investigation of Cardiovascular End Points (CONVINCE) trial.

Black HR, Elliott WJ, Grandits G, Grambsch P, Lucente T, White WB, Neaton JD, Grimm RH Jr, Hansson L, Lacourciere Y, Muller J, Sleight P, Weber MA, Williams G, Wittes J, Zanchetti A, Anders RJ; CONVINCE Research Group.

JAMA. 2003 Apr 23-30;289(16):2073-82.

PMID:
12709465
15.

Periodograms and pulse detection methods for pulsatile hormone data.

Grambsch P, Meller WH, Grambsch PV.

Stat Med. 2002 Aug 30;21(16):2331-44.

PMID:
12210618
16.

Major depression in unexplained infertility.

Meller W, Burns LH, Crow S, Grambsch P.

J Psychosom Obstet Gynaecol. 2002 Mar;23(1):27-30.

PMID:
12061034
17.

Fruits, vegetables, and adenomatous polyps: the Minnesota Cancer Prevention Research Unit case-control study.

Smith-Warner SA, Elmer PJ, Fosdick L, Randall B, Bostick RM, Grandits G, Grambsch P, Louis TA, Wood JR, Potter JD.

Am J Epidemiol. 2002 Jun 15;155(12):1104-13.

PMID:
12048224
18.

Rhythmicity in the regulation of luteinizing hormone release.

Meller WH, Grambsch PL.

Arch Gen Psychiatry. 2002 Jun;59(6):566. No abstract available.

PMID:
12044205
19.

Baseline Characteristics and Early Blood Pressure Control in the CONVINCE Trial.

Black HR, Elliott WJ, Neaton JD, Grandits G, Grambsch P, Grimm RH Jr, Hansson L, Lacoucière Y, Muller J, Sleight P, Weber MA, White WB, Williams G, Wittes J, Zanchetti A, Fakouhi TD, Anders RJ.

Hypertension. 2001 Jan;37(1):12-18.

PMID:
11208750
20.

Hypothalamic pituitary gonadal axis dysregulation in depressed women.

Meller WH, Grambsch PL, Bingham C, Tagatz GE.

Psychoneuroendocrinology. 2001 Apr;26(3):253-9.

PMID:
11166488
21.

Obtaining event status at the close of the Treatment of Mild Hypertension Study: methods and implication for other trials.

Grandits GA, Grimm RH Jr, Prineas RJ, Grambsch P, Holland LA.

Control Clin Trials. 2001 Feb;22(1):56-61.

PMID:
11165424
22.

Effect of calcium supplementation on serum cholesterol and blood pressure. A randomized, double-blind, placebo-controlled, clinical trial.

Bostick RM, Fosdick L, Grandits GA, Grambsch P, Gross M, Louis TA.

Arch Fam Med. 2000 Jan;9(1):31-8; discussion 39.

PMID:
10664640
23.

Colorectal adenomatous and hyperplastic polyps: smoking and N-acetyltransferase 2 polymorphisms.

Potter JD, Bigler J, Fosdick L, Bostick RM, Kampman E, Chen C, Louis TA, Grambsch P.

Cancer Epidemiol Biomarkers Prev. 1999 Jan;8(1):69-75.

24.

Rationale and design for the Controlled ONset Verapamil INvestigation of Cardiovascular Endpoints (CONVINCE) Trial.

Black HR, Elliott WJ, Neaton JD, Grandits G, Grambsch P, Grimm RH Jr, Hansson L, Lacoucière Y, Muller J, Sleight P, Weber MA, White WB, Williams G, Wittes J, Zanchetti A, Fakouhi TD.

Control Clin Trials. 1998 Aug;19(4):370-90.

PMID:
9683312
25.

Colorectal epithelial cell proliferative kinetics and risk factors for colon cancer in sporadic adenoma patients.

Bostick RM, Fosdick L, Grandits GA, Lillemoe TJ, Wood JR, Grambsch P, Louis TA, Potter JD.

Cancer Epidemiol Biomarkers Prev. 1997 Dec;6(12):1011-9.

26.

Methodological findings and considerations in measuring colorectal epithelial cell proliferation in humans.

Bostick RM, Fosdick L, Lillemoe TJ, Overn P, Wood JR, Grambsch P, Elmer P, Potter JD.

Cancer Epidemiol Biomarkers Prev. 1997 Nov;6(11):931-42.

27.

Hormone replacement therapy is associated with lower risk of adenomatous polyps of the large bowel: the Minnesota Cancer Prevention Research Unit Case-Control Study.

Potter JD, Bostick RM, Grandits GA, Fosdick L, Elmer P, Wood J, Grambsch P, Louis TA.

Cancer Epidemiol Biomarkers Prev. 1996 Oct;5(10):779-84.

28.

Diagnostic plots to reveal functional form for covariates in multiplicative intensity models.

Grambsch PM, Therneau TM, Fleming TR.

Biometrics. 1995 Dec;51(4):1469-82.

PMID:
8589234
29.

Calcium and colorectal epithelial cell proliferation in sporadic adenoma patients: a randomized, double-blinded, placebo-controlled clinical trial.

Bostick RM, Fosdick L, Wood JR, Grambsch P, Grandits GA, Lillemoe TJ, Louis TA, Potter JD.

J Natl Cancer Inst. 1995 Sep 6;87(17):1307-15.

PMID:
7658483
30.

Goodness-of-fit and diagnostics for proportional hazards regression models.

Grambsch PM.

Cancer Treat Res. 1995;75:95-112. Review. No abstract available.

PMID:
7640169
31.

Statistical analysis of proliferative index data in clinical trials.

Grambsch P, Louis TA, Bostick RM, Grandits GA, Fosdick L, Darif M, Potter JD.

Stat Med. 1994 Aug 30;13(16):1619-34.

PMID:
7973238
32.

Primary biliary cirrhosis: prediction of short-term survival based on repeated patient visits.

Murtaugh PA, Dickson ER, Van Dam GM, Malinchoc M, Grambsch PM, Langworthy AL, Gips CH.

Hepatology. 1994 Jul;20(1 Pt 1):126-34.

PMID:
8020881
33.

Piecewise exponential survival curves with smooth transitions.

Zelterman D, Grambsch PM, Le CT, Ma JZ, Curtsinger JW.

Math Biosci. 1994 Apr;120(2):233-50.

PMID:
8204986
34.

Association between survival time and ordinal covariates.

Le CT, Grambsch PM, Louis TA.

Biometrics. 1994 Mar;50(1):213-9.

PMID:
8086604
35.

Calcium and colorectal epithelial cell proliferation: a preliminary randomized, double-blinded, placebo-controlled clinical trial.

Bostick RM, Potter JD, Fosdick L, Grambsch P, Lampe JW, Wood JR, Louis TA, Ganz R, Grandits G.

J Natl Cancer Inst. 1993 Jan 20;85(2):132-41.

PMID:
8418302
36.

Primary sclerosing cholangitis: refinement and validation of survival models.

Dickson ER, Murtaugh PA, Wiesner RH, Grambsch PM, Fleming TR, Ludwig J, LaRusso NF, Malinchoc M, Chapman RW, Kaplan MM, et al.

Gastroenterology. 1992 Dec;103(6):1893-901.

PMID:
1451982
37.

Primary sclerosing cholangitis: value of cholangiography in determining the prognosis.

Craig DA, MacCarty RL, Wiesner RH, Grambsch PM, LaRusso NF.

AJR Am J Roentgenol. 1991 Nov;157(5):959-64.

PMID:
1927817
38.

The incidence of Peyronie's disease in Rochester, Minnesota, 1950 through 1984.

Lindsay MB, Schain DM, Grambsch P, Benson RC, Beard CM, Kurland LT.

J Urol. 1991 Oct;146(4):1007-9.

PMID:
1895413
39.

Normative sexual behavior in children.

Friedrich WN, Grambsch P, Broughton D, Kuiper J, Beilke RL.

Pediatrics. 1991 Sep;88(3):456-64.

PMID:
1881723
40.

Primary biliary cirrhosis: relation between hepatic function and pulmonary function in patients who never smoked.

Krowka MJ, Grambsch PM, Edell ES, Cortese DA, Dickson ER.

Hepatology. 1991 Jun;13(6):1095-100.

PMID:
2050328
41.

The effects of transformations and preliminary tests for non-linearity in regression.

Grambsch PM, O'Brien PC.

Stat Med. 1991 May;10(5):697-709.

PMID:
2068422
42.

Intrapartum intervention and delivery outcome in low-risk pregnancy.

Olson CL, Chaska BW, Grambsch PM, Wiltgen CM, Nesse RE.

J Am Board Fam Pract. 1991 Mar-Apr;4(2):83-8.

PMID:
2028829
43.

Diminished survival in asymptomatic primary biliary cirrhosis. A prospective study.

Balasubramaniam K, Grambsch PM, Wiesner RH, Lindor KD, Dickson ER.

Gastroenterology. 1990 Jun;98(6):1567-71.

PMID:
2338193
44.
45.

Extramural cross-validation of the Mayo primary biliary cirrhosis survival model establishes its generalizability.

Grambsch PM, Dickson ER, Kaplan M, LeSage G, Fleming TR, Langworthy AL.

Hepatology. 1989 Nov;10(5):846-50.

PMID:
2680867
46.

Primary sclerosing cholangitis: natural history, prognostic factors and survival analysis.

Wiesner RH, Grambsch PM, Dickson ER, Ludwig J, MacCarty RL, Hunter EB, Fleming TR, Fisher LD, Beaver SJ, LaRusso NF.

Hepatology. 1989 Oct;10(4):430-6.

PMID:
2777204
47.

Prognosis in primary biliary cirrhosis: model for decision making.

Dickson ER, Grambsch PM, Fleming TR, Fisher LD, Langworthy A.

Hepatology. 1989 Jul;10(1):1-7.

PMID:
2737595
48.

Patterns of failure after total laryngectomy for glottic carcinoma.

Foote RL, Buskirk SJ, Stanley RJ, Grambsch PM, Olsen KD, DeSanto LW, Earle JD, Weiland LH.

Cancer. 1989 Jul 1;64(1):143-9.

PMID:
2731110
49.

Efficacy of liver transplantation in patients with primary biliary cirrhosis.

Markus BH, Dickson ER, Grambsch PM, Fleming TR, Mazzaferro V, Klintmalm GB, Wiesner RH, Van Thiel DH, Starzl TE.

N Engl J Med. 1989 Jun 29;320(26):1709-13.

PMID:
2659986
50.

Application of the Mayo primary biliary cirrhosis survival model to Mayo liver transplant patients.

Grambsch PM, Dickson ER, Wiesner RH, Langworthy A.

Mayo Clin Proc. 1989 Jun;64(6):699-704.

PMID:
2664365

Supplemental Content

Loading ...
Support Center